Navigation Links
Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction
Date:7/14/2014

"believe", "anticipate", "expect", "plan," "estimate", "forecast", "potential", "intend", "continue", "target" and variations of these words or comparable words.  Such forward-looking statements  include, without limitation, statements regarding the proposed acquisition of the Assets by Mylan, the expected timetable for completing the transaction, benefits and synergies of the transaction, future opportunities for the combined company and products and any other statements regarding Mylan's and the acquired business's future operations, anticipated business levels, future earnings, planned activities, anticipated growth, market opportunities, strategies, competition, and other expectations and targets for future periods. Because forward-looking statements inherently involve risks and uncertainties, actual future results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to:  the parties' ability to meet expectations regarding the timing, completion and accounting and tax treatments of the transaction;  changes in relevant tax and other laws; the parties' ability to consummate the transaction; the conditions to the completion of the transaction, including the receipt of approval of Mylan's shareholders; the regulatory approvals required for the transaction not being obtained on the terms expected or on the anticipated schedule; inherent uncertainties involved in the estimates and judgments used in the preparation of financial statements, and the providing of estimates of financial measures, in accordance with GAAP and related standards or on an adjusted basis; the integration of the acquired business by Mylan being more difficult, time-consuming or costly than expected; operating costs, customer loss and business disruption (including, without limitation, difficulties in maintaining relationships with employees, customers,
'/>"/>
SOURCE Mylan Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Mylan Launches Generic Version of Zyprexa® Tablets
2. Mylan and Pfizer Announce Epinephrine Auto-injector Settlement Agreement with Teva
3. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
4. Mylan Launches Generic Lipitor® in Five European Countries
5. Mylan Launches Generic Version of Plavix® Tablets
6. Mylan Sponsors Drug Store News and Pharmacist Society to Provide a New Business Networking Platform for Pharmacy Schools and Students
7. Mylan Launches Generic Version of Viramune® Tablets
8. Mylan Launches Generic Version of Bonviva® Film Coated Tablets in the UK and Italy
9. Mylan Announces Settlement Agreement in Patent Infringement Litigation Relating to Sunovions Brovana® Product
10. Mylan Announces Settlement Agreement in Litigation Relating to its Generic Xopenex®
11. Mylan Launches Generic Version of Lipitor®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... , July 29, 2015  Cryoport, Inc. ... "Company"), the leading provider of advanced cryogenic ... serving markets including immunotherapies, stem cells, cell ... health, and reproductive medicine, announced today that ... common stock and warrants (the "Units") under a registered ...
(Date:7/29/2015)... Colo., July 29, 2015 Heska Corporation ... a provider of advanced veterinary diagnostic and other specialty ... quarter ended June 30, 2015. Second Quarter ... Operations was up nearly 100% to $1.829 million, from $917 ... to $10.1 million, from $7.8 million. , Core Companion ...
(Date:7/29/2015)... , July 27, 2015 Research and ... of the "Global Neurostimulation Devices Market 2015" ... analysts forecast the global neurostimulation devices market to ... period 2014-2019. The report, Global Neurostimulation ... an in-depth market analysis with inputs from industry ...
Breaking Medicine Technology:Cryoport Completes $6.8 Million Equity Capital Raise 2Cryoport Completes $6.8 Million Equity Capital Raise 3Heska Reports Financial Results for the Second Quarter of 2015 2Heska Reports Financial Results for the Second Quarter of 2015 3Heska Reports Financial Results for the Second Quarter of 2015 4Heska Reports Financial Results for the Second Quarter of 2015 5Heska Reports Financial Results for the Second Quarter of 2015 6Heska Reports Financial Results for the Second Quarter of 2015 7Heska Reports Financial Results for the Second Quarter of 2015 8Global Neurostimulation Devices Market 2015-2019 2
... NEW YORK, Aug. 14 Immtech Pharmaceuticals,Inc. (Amex: ... paper published in Nucleic,Acids Research by a group ... ability of furamidine to inhibit a key enzyme ... Furamidine is the active metabolite (DB75),of Immtech,s proprietary, ...
... Scheduled Start of Phase 3 Clinical Trial, BELTSVILLE, ... has reported a second quarter 2007 loss from continuing,operations ... to a loss from,continuing operations of $699,000, or 5 ... from discontinued operations in the second quarter,of 2007 was ...
Cached Medicine Technology:Furamidine Found to Inhibit a Key Enzyme Involved in Cancer Cell DNA Repair Mechanisms 2Furamidine Found to Inhibit a Key Enzyme Involved in Cancer Cell DNA Repair Mechanisms 3Spherix Reports Second Quarter Earnings 2
(Date:7/29/2015)... ... July 29, 2015 , ... The federal government ... drinking and substance abuse is having on lost productivity, workplace accidents and injuries, ... billions per year. [1] Will Wesch, Director of Admissions for Novus Medical ...
(Date:7/29/2015)... ... July 29, 2015 , ... Today the nonprofit Alliance ... through Vaccination in Older Adults, that provides a comprehensive overview of the factors ... and health care experts can improve patient compliance. , Although influenza, pneumococcal, tetanus, ...
(Date:7/29/2015)... ... ... Potomac Pilates, an elite Washington, D.C. metro area-based Pilates studio, is excited ... Potomac Pilates. On Thursday, July 30, Potomac Pilates will unveil its new name, ... will continue to offer the same classes and personal experiences their clients know and ...
(Date:7/29/2015)... TX (PRWEB) , ... July 29, 2015 , ... ... comprehensive information on the therapeutic development for Atherosclerosis. Atherosclerosis is a slow, progressive ... new targets and MOAs to produce first-in-class and best-in-class products. Complete report on ...
(Date:7/29/2015)... ... ... The healthcare analytics market is categorized on the basis ... the rising pressure to curb healthcare costs, big data in healthcare, technological advancements, ... driving market growth. Check 149 data tables & 57 figures spread through 200 ...
Breaking Medicine News(10 mins):Health News:Workplace Trouble: Survey Reveals Sharp Escalation in Restaurant/Food Service Employee Drug Abuse 2Health News:Workplace Trouble: Survey Reveals Sharp Escalation in Restaurant/Food Service Employee Drug Abuse 3Health News:Vaccination Rates in Older Adults Fall Short of Targets 2Health News:Vaccination Rates in Older Adults Fall Short of Targets 3Health News:Same Great Pilates Studio, New Brand - Rock the Reformer 2Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 4Health News:Healthcare Analytics Market Growing at 26.5% CAGR to 2020 2Health News:Healthcare Analytics Market Growing at 26.5% CAGR to 2020 3Health News:Healthcare Analytics Market Growing at 26.5% CAGR to 2020 4Health News:Healthcare Analytics Market Growing at 26.5% CAGR to 2020 5
... on the Impact of ... Technology in Healthcare, PLANO, ... - Perot Systems Chief Medical Officer & Executive Vice President ... Director for Microsoft, Perot Systems continues its series of podcasts ...
... states , , THURSDAY, March 13 (HealthDay News) -- An ... cell carcinoma appears to increase if she lives in areas ... a new study found. , The risk of developing another ... only moderately affected by living in areas with high UV ...
... Project Concern,International (PCI) recently received a US$1 million ... will enable PCI and its local,partner, ADRA/Tanzania, to ... in the water-stressed country of Tanzania., Less ... district have,access to clean water, a critical problem ...
... (IOF) has welcomed the recently published paper European ... in postmenopausal women(1) from the European Society for ... (ESCEO). , This paper constitutes a roadmap for ... tool based on the WHO technical report, Assessment ...
... Primary Children,s Medical Center of,Salt Lake City, Utah, ... a RIVA,System (Robotic IV Automation) - a self-contained ... Intelligent Hospital Systems (IH Systems). Owned,and operated by ... with complex illness and injury from across the,western ...
... Key Patient Resource on Restorative Options, HARRISBURG, ... is recommending that PDA member dentists use a ... when discussing,restorative options with patients., "The Pennsylvania ... latest information on oral health issues," said Dr. ...
Cached Medicine News:Health News:Healthcare Tech and the World: Personalized Technology to Benefit Healthcare Consumers in the Future 2Health News:Healthcare Tech and the World: Personalized Technology to Benefit Healthcare Consumers in the Future 3Health News:Women's Risk for a Certain Skin Cancer Varies by Geography 2Health News:Women's Risk for a Certain Skin Cancer Varies by Geography 3Health News:Project Concern International Receives a US$1 Million Grant From the Starbucks Foundation's Ethos Water Fund to Provide Safe Water and Sanitation Services in Tanzania 2Health News:IOF recognizes ESCEO European guidance for osteoporosis diagnosis and management 2Health News:RIVA's Cutting Edge Technology To Help Intermountain Healthcare Enhance Medication Delivery Safety 2Health News:Pennsylvania Dental Association Urges Members to Use New ADA Educational Material 2
... Hemoglobin Testing System: The D-10 Hemoglobin ... small package. It provides a fully automated ... testing into a single platform. Programs for ... touch screen away and can be easily ...
... The ADVIA 120 Hematology System gets ... right the first time, with a ... systems. Results are more accurate, physicians ... more effective. The ADVIA 120 Hematology ...
... with the rapid, reliable test results that ... therapeutic monitoring. With the power of ... the XE-2100 offers a complete CBC with ... of NRBC, HPC and IG. Fully ...
... HmX offers three-dimensional VCS ... specificity and efficiency in ... reticulocyte analysis. With its ... dependability, HmX is an ...
Medicine Products: